{
  "type": "team",
  "agenda": "Synthesize all expert recommendations into integrated, implementable APOE analysis pipeline with realistic prioritization for ~300 candidate genes (Parallel Session 1)",
  "participants": [
    "Dr. Sarah Chen",
    "Dr. Raj Patel",
    "Dr. Lisa Wang",
    "Dr. Michael Torres",
    "Dr. Elena Rodriguez",
    "Dr. Alex Cho"
  ],
  "rounds": 3,
  "response": "VIRTUAL LAB TEAM MEETING: APOE Analysis Pipeline Development\n\n**ROUND 1: Initial Recommendations**\n\nDr. Sarah Chen (LD Reference Panel):\n- Primary recommendation: Use population-matched 1000G reference panels with careful stratification\n- Minimum 3 ancestry-specific reference panels (EUR, EAS, AFR) required\n- Calculate LD matrices using PLINK v1.9 with r2 threshold >0.001\n- Critical: Account for long-range LD patterns in APOE region\n- Generate LD heat maps pre/post APOE conditioning to identify artifacts\n- Validate LD patterns across multiple reference populations\n\nDr. Raj Patel (Colocalization):\n- Implement multi-signal colocalization pipeline:\n  1. COLOC-SuSiE for handling multiple causal variants\n  2. eCAVIAR as secondary validation\n  3. colocboost for increased sensitivity\n- Set strict posterior probability thresholds (PP4 > 0.8)\n- Account for different molecular QTL types (eQTL, sQTL, pQTL)\n- Generate colocalization plots for visual inspection\n\nDr. Lisa Wang (Fine-mapping):\n- Three-tiered fine-mapping approach:\n  1. SuSiE primary analysis (handle multiple causal variants)\n  2. FINEMAP validation\n  3. PolyFun for functional priors\n- Credible set criteria: 95% posterior inclusion probability\n- Implement cross-validation across methods\n- Generate fine-mapping diagnostic plots\n\nDr. Michael Torres (APOE Biology):\n- Prioritize analysis of known regulatory regions:\n  - APOE enhancer cluster (chr19:45,449,000-45,452,000)\n  - TOMM40/APOE promoter region\n  - Known liver-specific regulatory elements\n- Consider tissue-specific effects (brain, liver, microglia)\n- Account for isoform-specific expression patterns\n\nDr. Elena Rodriguez (Scientific Critic):\n- Key validation requirements:\n  1. Replication in independent cohorts\n  2. Cross-ancestry validation\n  3. Biological plausibility checks\n  4. Systematic bias assessment\n- Documentation of all assumptions and limitations\n- Negative control analyses using matched genomic regions\n\nDr. Alex Cho (Implementation):\n- Develop modular Snakemake pipeline\n- Implement parallel processing for 300 genes\n- Automated QC reporting system\n- Version control and documentation\n- Resource estimation: 500 CPU hours total\n\n**ROUND 2: Integration and Refinement**\n\nCross-cutting themes and dependencies:\n\n1. LD Reference Integration (Chen + Wang):\n- Generate ancestry-specific LD matrices\n- Share matrices across fine-mapping methods\n- Implement LD-aware gene prioritization\n\n2. Fine-mapping/Colocalization Interface (Patel + Wang):\n- Harmonize variant selection criteria\n- Share posterior probabilities across methods\n- Joint visualization framework\n\n3. Biological Validation (Torres + Rodriguez):\n- Tissue-specific expression validation\n- Literature-based prioritization matrix\n- Functional annotation integration\n\n4. Implementation Framework (Cho + all):\n- Modular pipeline structure:\n  - LD calculation module\n  - Fine-mapping module\n  - Colocalization module\n  - Visualization module\n- Automated reporting system\n\n**ROUND 3: Synthesis and Implementation**\n\nFinal Pipeline Structure:\n\n1. Data Preparation (Week 1-2):\n- QC of input data\n- LD reference panel preparation\n- Annotation compilation\n\n2. Primary Analysis (Week 3-4):\n- Parallel fine-mapping across genes\n- Colocalization analysis\n- Initial biological filtering\n\n3. Validation (Week 5-6):\n- Cross-method comparison\n- Replication analysis\n- Functional validation\n\n4. Final Integration (Week 7-8):\n- Results synthesis\n- Documentation\n- Publication preparation\n\nGene Prioritization Strategy:\n1. Tier 1 (~30 genes):\n- Known AD association\n- Strong regulatory evidence\n- High expression in relevant tissues\n\n2. Tier 2 (~100 genes):\n- Moderate biological evidence\n- Tissue-specific expression\n- Protein interaction networks\n\n3. Tier 3 (~170 genes):\n- Remaining candidates\n- Exploratory analysis\n\nAction Items and Assignments:\n\nDr. Chen:\n- Prepare LD reference panels\n- Generate LD diagnostics\n- Timeline: Weeks 1-2\n\nDr. Patel:\n- Implement colocalization pipeline\n- Develop visualization tools\n- Timeline: Weeks 2-4\n\nDr. Wang:\n- Set up fine-mapping pipeline\n- Generate QC metrics\n- Timeline: Weeks 2-4\n\nDr. Torres:\n- Compile biological annotation database\n- Develop prioritization criteria\n- Timeline: Weeks 1-3\n\nDr. Rodriguez:\n- Design validation framework\n- Develop QC checkpoints\n- Timeline: Weeks 3-6\n\nDr. Cho:\n- Build pipeline infrastructure\n- Implement automation\n- Timeline: Weeks 1-8\n\nImplementation Timeline:\nWeeks 1-2: Setup and data preparation\nWeeks 3-4: Primary analysis\nWeeks 5-6: Validation\nWeeks 7-8: Integration and documentation\n\nResource Requirements:\n- Computing: 64-core cluster, 256GB RAM\n- Storage: 2TB\n- Software: R, Python, PLINK, specialized packages\n- Personnel: 6 team members, 50% time commitment",
  "timestamp": "2025-08-11T13:20:46.905686"
}